Massachusetts Financial Services Co. MA Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Massachusetts Financial Services Co. MA cut its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 61.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 298,559 shares of the healthcare conglomerate’s stock after selling 466,037 shares during the period. Massachusetts Financial Services Co. MA’s holdings in UnitedHealth Group were worth $150,530,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of UNH. Robbins Farley acquired a new stake in UnitedHealth Group during the third quarter worth approximately $25,000. NewSquare Capital LLC raised its stake in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares during the period. Strategic Investment Solutions Inc. IL purchased a new position in UnitedHealth Group during the first quarter worth approximately $35,000. WFA of San Diego LLC purchased a new position in UnitedHealth Group during the second quarter worth approximately $39,000. Finally, Annapolis Financial Services LLC raised its stake in UnitedHealth Group by 38.6% during the third quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock worth $40,000 after purchasing an additional 22 shares during the period. 85.69% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have weighed in on UNH shares. Morgan Stanley cut their price target on shares of UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating on the stock in a research note on Monday, October 23rd. Piper Sandler cut their target price on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 17th. UBS Group raised shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and raised their target price for the company from $520.00 to $640.00 in a research note on Monday, October 16th. HSBC reissued a “reduce” rating and issued a $480.00 target price (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Finally, StockNews.com downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 21st. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $575.79.

Check Out Our Latest Stock Report on UNH

UnitedHealth Group Stock Up 1.5 %

NYSE:UNH opened at $510.73 on Wednesday. The firm has a market capitalization of $472.38 billion, a PE ratio of 21.42, a price-to-earnings-growth ratio of 1.37 and a beta of 0.54. The stock has a 50 day moving average of $526.91 and a 200-day moving average of $517.63. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70. The company has a current ratio of 0.79, a quick ratio of 0.80 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.98 by $0.18. The business had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business’s revenue was up 14.1% on a year-over-year basis. During the same period in the previous year, the firm posted $5.34 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 27.84 EPS for the current year.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 66,081 shares of the company’s stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total value of $36,370,321.59. Following the completion of the sale, the director now directly owns 635,528 shares in the company, valued at $349,788,255.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.